Podcasts about Childhood cancer

In this episode of the Gladden Longevity Podcast, Dr. Jeffrey Gladden interviews Vlad Vukicevic , CEO and founder of the Better & Better, who shares his remarkable journey from childhood cancer survivor to entrepreneur in the health and wellness space. The conversation explores themes of longevity, health challenges, mental health, and innovative health products, emphasizing the importance of preventive care and personal growth.   For Audience ·       Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/ !      Takeaways ·       Vlad's journey began with a cancer diagnosis at age five. ·       He underwent extensive treatment, including chemotherapy and a bone marrow transplant. ·       The experience shaped his understanding of mortality and health. ·       Vlad's family provided crucial support during his health challenges. ·       He developed a hypochondriac tendency due to his past health issues. ·       Vlad emphasizes the importance of ongoing health monitoring. ·       He founded Better and Better to innovate in health products. ·       The company focuses on integrating health benefits into everyday routines. ·       Vlad believes in continuous improvement in health and wellness. ·       He aims to make health management easier for everyone.     Chapters 00:00 Introduction to Longevity and Health 01:34 Vladimir's Early Health Challenges 04:43 The Impact of Childhood Cancer 09:06 Coping with Mortality and Mental Health 13:42 Navigating Teenage Years Post-Cancer 17:16 Ongoing Health Monitoring and Preventive Care 19:59 The Evolution of Health Awareness 22:46 Entrepreneurial Journey and Health Innovations 27:24 The Future of Health Products 32:00 Conclusion and Personal Growth   To learn more about Vlad: Website: https://www.betterandbetter.com/   Reach out to us at:    Website: https://gladdenlongevity.com/     Facebook: https://www.facebook.com/Gladdenlongevity/    Instagram: https://www.instagram.com/gladdenlongevity/?hl=en     LinkedIn: https://www.linkedin.com/company/gladdenlongevity    YouTube: https://www.youtube.com/channel/UC5_q8nexY4K5ilgFnKm7naw   Gladden Longevity Podcast Disclosures Production & Independence The Gladden Longevity Podcast and Age Hackers are produced by Gladden Longevity Podcast, which operates independently from Dr. Jeffrey Gladden's clinical practice and research at Gladden Longevity in Irving, Texas. Dr. Gladden may serve as a founder, advisor, or investor in select health, wellness, or longevity-related ventures. These may occasionally be referenced in podcast discussions when relevant to educational topics. Any such mentions are for informational purposes only and do not constitute endorsements. Medical Disclaimer The Gladden Longevity Podcast is intended for educational and informational purposes only. It does not constitute the practice of medicine, nursing, or other professional healthcare services — including the giving of medical advice — and no doctor–patient relationship is formed through this podcast or its associated content. The information shared on this podcast, including opinions, research discussions, and referenced materials, is not intended to replace or serve as a substitute for professional medical advice, diagnosis, or treatment. Listeners should not disregard or delay seeking medical advice for any condition they may have. Always seek the guidance of a qualified healthcare professional regarding any questions or concerns about your health, medical conditions, or treatment options. Use of information from this podcast and any linked materials is at the listener's own risk. Podcast Guest Disclosures Guests on the Gladden Longevity Podcast may hold financial interests, advisory roles, or ownership stakes in companies, products, or services discussed during their appearance. The views expressed by guests are their own and do not necessarily reflect the opinions or positions of Gladden Longevity, Dr. Jeffrey Gladden, or the production team. Sponsorships & Affiliate Disclosures To support the creation of high-quality educational content, the Gladden Longevity Podcast may include paid sponsorships or affiliate partnerships. Any such partnerships will be clearly identified during episodes or noted in the accompanying show notes. We may receive compensation through affiliate links or sponsorship agreements when products or services are mentioned on the show. However, these partnerships do not influence the opinions, recommendations, or clinical integrity of the information presented. Additional Note on Content Integrity All content is carefully curated to align with our mission of promoting science-based, ethical, and responsible approaches to health, wellness, and longevity. We strive to maintain the highest standards of transparency and educational value in all our communications.

Drop your toys off at any of the PEM school offices before December 1st to help out!

Guest Dr. Rusha Bhandari and host Dr. Davide Soldato discuss JCO article "Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study, " with a particular focus on mortality data, development of secondary malignancies and the importance of education for both patients and healthcare providers regarding long-term follow-up and care. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Dr. Davide Soldato: Hello, and welcome to JCO After Hours, the podcast where we sit down with authors from some of the latest articles published in the Journal of Clinical Oncology. I am your host, Dr. Davide Soldato, Medical Oncologist at Ospedale Policlinico San Martino in Genoa, Italy. Today, we are joined by JCO author, Dr. Rusha Bhandari, a Pediatric Hematologist-Oncologist and Assistant Professor in the Department of Pediatrics and Population Science at City of Hope, California. Today, we will be discussing the article titled "Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study." So, thank you for speaking with us, Dr. Bhandari. Dr. Rusha Bhandari: Thanks so much for having me. Dr. Davide Soldato: So, I just want to go straight ahead in the paper and start from the title. So, we heard that you included in this study childhood survivors of pediatric cancer that were aged 50 years or higher. So, this is a very critical life stage when we know that there are a lot of aging-related comorbidities that can happen, also in the general population but potentially specifically in childhood cancer survivors. So, first of all, I wanted to ask you, why this specific study in this very specific population? Because I think that we had already some data in younger survivors, but now we are focusing specifically on patients aged 50 or more. Dr. Rusha Bhandari: Absolutely. So, to answer that question, I'll take a little bit of a step back in terms of where we are now and where we came from in terms of treatment for childhood cancers. So, thankfully, we now have great curative therapies and survival rates for many childhood cancers, including the most common ones. But this was not necessarily the case 50 or more years ago. So, we essentially are now seeing the first generation of older survivors who are 30, 40, or more years from completion of their cancer treatment. As you pointed out, we know from younger survivors that they have a markedly higher risk of malignancies and health conditions than the general population. You don't typically expect to see things like heart disease or diabetes, for example, in a young adult. But the question that remained was what the health status and risk of these conditions are in survivors who are entering this critical age, as you mentioned, 50 or older, when you do start to see these aging-related changes in the general population. And the question is whether we're still observing increased risks related to cancer treatment that was delivered 30 or more years ago in these survivors who are now entering ages 50 and beyond. Dr. Davide Soldato: Thanks so much. You used the data from a study that is called the Childhood Cancer Survivor Study. So, just a little bit of explanation for our listeners. How is the study conducted? What type of data are you collecting? And specifically for the interest of the study that was reported in this manuscript, which outcomes were really important for you and were so evaluated in the manuscript? Dr. Rusha Bhandari: Yes. So, the Childhood Cancer Survivor Study is a really excellent resource that combines information from children who were treated across North America at various different centers and sites. So it gives us a really good understanding of how different survivors are doing as they do progress through their survivorship journey. The Childhood Cancer Survivor Study includes a baseline questionnaire when participants are first eligible or first enter the study, and then includes a series of follow-up questionnaires to really understand how they're doing, like I mentioned, as they progress throughout their survivorship journey. And so for this study, we really wanted to take a global look at how these patients were doing as they entered that older age range. And so we wanted to look at outcomes ranging from mortality through the health conditions that we've seen from other survivorship studies, including subsequent malignant neoplasms, other health conditions, I mentioned earlier heart disease and other comorbidities we know survivors can be at increased risk for, and also things like frailty, which we know is, you know, the most widely recognized phenotype of aging. And we see that earlier on in our younger survivors. We want to see how this translated to these older survivors and then also other health outcomes like their health status. What is their self-report of their physical health, their mental health? Things like that. So we wanted a very comprehensive understanding of their health. Dr. Davide Soldato: This is a very comprehensive study. Right now it includes more than 30,000 patients that have been treated for childhood cancer, but specifically looking at the question of survivors aged 50 years or higher, you included more than 7,000 patients inside of this study. So, looking at the first outcome that you mentioned, which I think it's also one of the most important, you look specifically at mortality, and in this specific population, you saw a striking three-fold increase in mortality when comparing these survivors with the general population. I just wanted to dive in this result and ask you: What do you see as the main driver for this excess mortality in this population of survivors? And as you were mentioning, the study also collects information about the treatment received. So, was there any association with a specific kind of treatment that was received for curing these childhood cancers? Dr. Rusha Bhandari: I agree. I would say it's striking to see that mortality risk among the survivors relative to the general population. And we do know, again from prior studies, that survivors of childhood cancer do have an increased risk of mortality compared to the general population, but I think looking at those curves of the cumulative mortality risk was really quite striking as they diverge, and that's, you know, just so long past their initial diagnosis and treatment. We know that subsequent malignant neoplasms or secondary cancers are a really an important contributor to mortality among survivors. And I think it was important to note that even in these older survivors, it's still such an important contributor to mortality, and I think this really highlights the need for us to better understand what is driving specific secondary cancers and what are the differences in the biology and treatment approaches for some of these cancers? And how might that then be contributing to the mortality risk? Dr. Davide Soldato: Related to the treatment mortalities - because I think that one of the main forces of the study, as it is conducted, is that it contains a lot of information regarding radiotherapy, allogeneic transplant, surgery, type of chemotherapy received by these survivors - so, are we able right now with the data that we have to pinpoint which of these treatments can potentially lead to such increased risk of mortality? Dr. Rusha Bhandari: So, we weren't able to look at the comprehensive treatment exposures and mortality risk for this paper. So that might be one of the questions I would put on the side. We were able to look at that in relation to subsequent malignant neoplasms and health conditions though, as you mentioned. Dr. Davide Soldato: Another thing that I think is very important is that you were able to look at specific causes for mortality. So for example, you mentioned the increased rate of neoplasm in this population and specifically, more or less 7.6% of the patients that were included in the study developed another neoplasm after the ones they were cured for in the childhood period. So, you saw a wide range of cancer, for example, bone and soft tissue sarcomas, breast cancer, genitourinary cancer. And as you were mentioning, there were some associations for treatment modalities that were associated with a higher risk of developing this type of cancer. Can you expand a little bit on this? Dr. Rusha Bhandari: Absolutely. And so the key part here was that we really looked at any of these outcomes that occurred beyond age 50. What we found was there is still an increased risk of secondary cancers beyond that initial childhood cancer diagnosis, but when we really looked at that data, it was specifically among survivors who had a history of receiving radiation. And we did not necessarily see an association between different chemotherapy exposures and secondary cancers. And I think this speaks to what we're now learning in terms of the very long-term effects of radiation and how that impacts ongoing health risk even in patients who are 30 or more years out from their treatment. And I think it really highlights the importance of these- the efforts that have been made in the more recent decades to really try and reduce or eliminate radiation where possible, you know, as we've come to understand more about these long-term effects from it. Dr. Davide Soldato: A clear association with radiation therapy but no association when we look at specific types of chemotherapy that were used for curing this childhood cancer. Another thing that I think it's very interesting and you briefly mentioned before is that potentially when we look at these secondary malignant neoplasm that develop in this situation, we might also see some outcomes that are not comparable to the one of the general population, meaning that we managed to cure less this type of cancer when they develop in these childhood survivors. So, I just wanted to understand if you could provide us with a little bit of perspective also from a clinical standpoint being a pediatric hematologist-oncologist as to why this might be happening and how can we potentially increase the cure rate also in this population of childhood cancer survivors? Dr. Rusha Bhandari: Absolutely. While that was not the focus of this study, it was something that we were certainly interested in is understanding how even once a childhood cancer survivor, for example, develops a health condition or a secondary cancer further into survivorship, how does that outcome then differ from someone in the general population? And there's a lot of interest in ongoing studies actually evaluating that and understanding what are the differences from the initial presentation, biology, the characteristics of that cancer, through how they're treated. So I don't know if we have all of the answers for that quite yet, but you can imagine if someone hypothetically had a history of receiving a lot of anthracycline chemotherapy or already having received a lot of radiation, that might impact what treatment they might receive for that secondary cancer or if they already have other existing comorbidities that need to be taken into consideration. Dr. Davide Soldato: Speaking about comorbidities, you were mentioning in the beginning that one of the focuses of this scientific work was really to try and see whether also this type of adverse health outcomes that can be potentially related to treatments were more frequent among these childhood cancer survivors. So I think that it's very interesting that for this comparison, you were able to use the data from the siblings of the patients who were included inside of the study. So, just a little bit of a comment on why you decided to use this specific methodology, which I think has a very nice touch to it when we look at these outcomes like, for example, diabetes or cardiovascular disease, and in general, do we see an increased number of chronic health conditions among survivors who were treated for childhood cancers? Dr. Rusha Bhandari: Yes, so this is a really excellent strength of the Childhood Cancer Survivor Study is that they have information, longitudinal information, on survivors as well as their siblings. So, you know, when we were discussing the design of the study, I mentioned that we have initial baseline questionnaires as well as multiple follow-up questionnaires, and that is for both the survivors and the siblings. And so we're able to really understand their health course over time. We chose to evaluate sibling data because then you're really able to look at people who have similar characteristics, right? Similar environmental exposures in theory, potentially similar genetic predispositions and makeups and things like that. And so you can really try and have as good of a comparison as possible. Dr. Davide Soldato: Did we see any increase in chronic health condition when looking at survivors compared to the siblings? Dr. Rusha Bhandari: We did. And while that's been reported before, again, I think it's important to demonstrate that in this older population when you would expect that these siblings would now also be starting to develop different health conditions. Dr. Davide Soldato: One thing that was very interesting is that when we look at the coexistence of multiple comorbid conditions and chronic condition in this population, we also see that for some of these survivors, they basically have the same rates of comorbidities as compared to siblings who are potentially 20 years older than them. So I think that there is really that striking point, as you were mentioning before, of accumulation of changes, also physiological changes that can potentially drive a higher frailty index, which was also higher when looking at these survivors compared to their siblings. One outcome that was really not that worse when we look at survivors of childhood cancer was actually mental health. And as I read the paper, it was something that really surprised me a little bit because you would imagine that going through such a harsh diagnosis, such very complex treatment, very early in their life could potentially lead to some worse health outcomes also in terms of mental health over time. But this was not seen. And just a comment on this, because I think it's a very surprising data. Dr. Rusha Bhandari: Yes, I appreciate that question. So, as you mentioned, mental health is such an important issue for patients, both those undergoing treatment as well as those in long-term survivorship. And in our study, we found that survivors were not more likely, as you mentioned, to report poor mental health compared to their siblings. And I think there's a few possible reasons for this. You know, again, this is self-reported data amongst siblings and survivors who survived to at least 50 years of age and completed a questionnaire. And so that is the group of individuals that we were able to evaluate this in, so we have to keep that in mind. But I think our findings may also reflect the resilience of this particular cohort of aging survivors that we included. This finding has been reported in other studies of survivors as well, and so I think it very well may speak to the resilience of the cohort that we're looking at. Dr. Davide Soldato: Going back just a little bit, you mentioned that the majority potentially of these survivors who were included in the current analysis were treated between 1970s and 1980s. So, as you were mentioning before, radiotherapy was seen as a significant contributor to second neoplasm and also to the increase of this chronic health condition. So, do you believe that there is still a role for these survivorship studies as we are approaching treatment modalities where radiotherapy is administered less frequently or with lower doses or omitted at all in the treatment course of these survivors? Dr. Rusha Bhandari: Absolutely. I think you mentioned a very important point, which is these findings are most applicable to the patients who were included in this cohort or similar cohorts, those who were treated in the 1970s and 80s who now are 50 years or older at this point in time. And as you know, treatment modalities have really changed. You know, as you mentioned, we'll use less radiation in many cases whenever possible, but there are so many new modalities, so many different chemotherapeutic agents, immunotherapy. There's so much more we need to learn about the long-term effects of some of these newer treatment modalities. And also, we've been able to really intensify our treatment regimens with improvements in both treatment approaches and supportive care. And so I think we have a lot to learn about those late effects, and ongoing studies are certainly needed as we continue to have this growing population of older survivors. Dr. Davide Soldato: And now a more general question which builds on the results of the study but goes a little bit beyond what was the scope of the research. So we have just discussed that there is an excess mortality in general, there is a higher risk for secondary malignancies in this population, we see higher accumulation of chronic comorbid conditions that need to be treated. So building on these results, in your opinion, what would be the best framework to follow up these patients over time? Because I imagine that for some of these patients who have been treated 30, 40 years before the moment where we see this type of events, they can be potentially also discharged from more specialistic medical care. So what is the best course of action? Should we keep all of these patients under observation in a very specialistic environment under the care of the oncologist or the pediatric oncologist? Should we create a stronger bond with general practitioners so they know that there is this problem? Dr. Rusha Bhandari: Yes, I mean, I think you're reading my mind. We thankfully do have evidence-based guidelines. We utilize the Children's Oncology Group Long-Term Follow-Up Guidelines, which include screening recommendations for secondary cancers, chronic health conditions, everything based on the underlying diagnosis and treatment that these patients received. But we recognize that a large proportion of these survivors do not continue to have lifelong follow-up at a survivorship center, but really do need that specialized screening based on their treatment that they received. And I think for that reason, it's so important that we continue to build relationships with their primary care providers and really make sure that both patients and their providers have this information at hand regarding what their treatment is and what the screening is that they need and that we be able to have this community whereby we are able to help inform the screening in our own survivorship clinics, but also help guide some of the primary care providers who are going to be seeing these patients in the long run. Dr. Davide Soldato: Do we have any data showing what is the adherence rate of these patients to this type of continuous screening and monitoring over time? Because I imagine that that might also be a point for improvement in terms of quality of care. Can we retain as much childhood cancer survivors as we want as we are learning that there are all these potential negative health outcomes over time? Dr. Rusha Bhandari: We definitely within the survivorship community do want to help make sure as many survivors as possible are being engaged, again, whether it's at their specific cancer center or whether it's in the community, recognizing that for many reasons, it's not feasible to always return to that cancer center for your regular survivorship care. I think there's a lot we can do. Going a little bit outside the scope of your question, but I think there's a lot that we can do nowadays in terms of telehealth and being able to communicate with patients and their providers even if they're geographically not located right near us. But we do have data that shows that the further out many patients get from their initial diagnosis and treatment, the less often they might follow up with a survivorship provider. Some of this varies by different treatment. Dr. Davide Soldato: So, basically the final question is that we need more education and potentially more resources for survivorship clinics and in general to better inform patients and providers about these potential long-term outcomes. Dr. Rusha Bhandari: That's certainly a focus of our survivorship program, for example, is to make sure that we're able to educate patients, inform them of their risks, and why certain screening tests are recommended at certain times in their survivorship journey. And then I think again, thankfully nowadays with all of the electronic medical records and different methods for us to communicate, there's a lot of opportunity for us to continue building these relationships with those primary care providers and making sure they have the information at their fingertips as well as to be able to work in conjunction with these patients to continue to formulate their plans and carry out these screenings and then again, like I was saying, have an easy open line of communication with the oncology centers if they do have any questions. Dr. Davide Soldato: Thanks so much. This brings us to the end of this episode. I would like to thank again Dr. Bhandari for joining us today. Dr. Rusha Bhandari: Thank you so much. It's been a real pleasure speaking with you. Dr. Davide Soldato: And we appreciate you sharing more on your JCO article titled "Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study." If you enjoy our show, please leave us a rating and review and be sure to come back for another episode. You can find all ASCO shows at asco.org/podcasts. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

In episode 96 of the Summits Podcast, co-hosts Vince Todd, Jr. and Daniel Abdallah are joined by Dr. Robyn Spoon, CEO of Elevate Childhood Cancer Research and Advocacy. Tune in as Robyn shares her son's cancer story that ignited a passion for change and how Elevate Childhood Cancer Research and Advocacy is moving the needle on precision medicine for those diagnosed with childhood cancer. Learn more about Elevate Childhood Cancer Research and Advocacy at elevatechildhoodcancer.org. The Heroes Foundation Team JOEY Program proudly sponsored the 2nd Annual Indiana Pediatric Sarcoma Research & Advocacy Summit. Together, we will continue uniting Indiana against cancer.

Alex Conley has lived every phase of the wellness journey, from surviving childhood cancer to chasing fitness perfection to realizing that health isn't something you buy, it's something you build through integrity and awareness. In this episode, Alex shares how years in the fitness and supplement industries exposed the cracks in our modern health system — from FDA loopholes and overprocessed supplements to the corruption of Big Food and the destruction of our soil. He explains why simplicity is the real cure, what we get wrong about hydration, and how mental health, anger, and anxiety are symptoms of a deeper imbalance in the way we live. We also cover: Why only 12% of second opinions confirm the original diagnosis How the supplement industry gets away with harmful ingredients What 98% of conventional farming means for your health The connection between soil quality, nutrition, and mental well-being Why the cure has always been simple — and how to return to it This conversation will challenge what you think you know about “wellness” and remind you that healing doesn't have to be complicated. Resources: → CURED | Right now, CURED Nutrition is offering my listeners an exclusive 20% off ON TOP OF the 10% off Best Seller Bundle. Just head to https://www.curednutrition.com/CLAUDIA and use the code CLAUDIA at checkout → PUORI | Shop Puori grass-fed protein powder + supplements (Clean Label Certified and third-party tested!!!) Use discount code: HEALINGTHESOURCE Follow Alex on Instagram Check out KONO's website for holistically formulated supplements. Discount code: HEALING Follow the host, Claudia, on Instagram, check out HealingTheSource.co & Elham's Liquid Gold 100% Organic Castor Oil, and enjoy her deep-dives on Substack

In this powerful episode of the Game Over: c*ncer, hosts Dana and Val sit down with Maria Ochoa, president and co-founder of Mia's Miracles Foundation. Maria, along with her husband, professional golfer Camilo Villegas, created Mia's Miracles in honor of their daughter Mia, who passed away from brain and spine cancer at just 22 months old.Maria opens up about surrender, grief, PTSD, and the unseen weight caregivers carry. She shares how love, boundaries, and support can transform the hardest seasons. She shares Mia's story, the impact of treatment on the family, and why caregiver well-being is essential to a child's care. Maria also discusses her own recent health battles, the choices she made, and the peace she's found on the other side, offering wisdom for anyone navigating fear, trauma, or loss.In this episode we explore:The reality of pediatric cancer for the whole family, and why caregiver health mattersGrief, fear, and PTSD: naming it, facing it, and finding tools to healBoundaries, marriage, and moving through hard things togetherThe mission and impact of Mia's Miracles Foundation Practical ways anyone can help, because small gifts add up to big changeConnect with our guest and learn about and support Mia's Miracles Foundation at:mias-miracles.orgIf this conversation moves you, please like, comment, and share to help us educate for change. Leaving a review helps more families find tangible hope.Tune in to hear this inspiring and informative conversation. Don't forget to subscribe, leave a review, and join the fight to make Game Over: c*ncer a reality.Connect with Dana: https://www.linkedin.com/in/danaknichols/Connect with Val: https://www.linkedin.com/in/valerie-solomon/Upcoming Ckc Events: https://cannonballkidscancer.org/category/make-an-impact/events/----------------------------------Podcast Produced by Hi Hello Labs: Website: https://www.hihellolabs.com/

Commentary by Yi Li, MA.

Dr. Uri Tabori is a Staff Physician in the Division of Haematology/Oncology, Senior Scientist in the Genetics & Genome Biology program, and Principal Investigator of The Arthur and Sonia Labatt Brain Tumour Research Centre at The Hospital for Sick Children (SickKids). Uri is also a Professor in Paediatrics and Associate Professor in the Institute of Medical Sciences at the University of Toronto. Uri works as a physician treating kids with cancer, particularly brain tumors. Through his research, he is working to identify drugs and make new discoveries that may cure cancers or improve patients' lives. When he's not hard at work in the lab or clinic, Uri enjoys spending time with his family, watching American football, and exploring the wilderness of Canada. He is especially fond of canoeing and canoe camping with his family. He received his MD from the Hadassah School of Medicine of Hebrew University in Israel. Afterwards, he completed a Rotating Internship and his Residency in Pediatrics at the Sorasky Medical Center in Israel. Next, Uri accepted a Fellowship in Pediatric Hematology and Oncology at the Sheba Medical Center in Israel. He served as a Staff Physician in Pediatric Hematology and Oncology at The Sheba Medical Center for about a year before accepting a Research and Clinical Fellowship at The Hospital for Sick Children in Canada SickKids where he remains today. Over the course of his career, Uri has received numerous awards and honors, including the Early Researcher Award from the Ontario Ministry of Development and Innovation, the New Investigator Award from the Canadian Institute of Health Research, the Junior Physician Research Award from the University of Toronto Department of Pediatrics, The New Investigator Award from the Terry Fox Foundation, A Eureka! new investigator award from the International Course of Translational Medicine, A Merit Award from the American Society of Clinical Oncology Annual Meeting, and The Young Investigator Award from the Canadian Neuro-Oncology Society. In our interview, Uri shares more about his life, science, and clinical care.

Aubrey Masango speaks to Bonita Suckling, Founder of Rainbows and Smiles NPO to discuss the organization's mission and the vital work they do in providing emotional, social, and financial support to children with cancer and their families across South Africa. The Aubrey Masango Show is presented by late night radio broadcaster Aubrey Masango. Aubrey hosts in-depth interviews on controversial political issues and chats to experts offering life advice and guidance in areas of psychology, personal finance and more. All Aubrey’s interviews are podcasted for you to catch-up and listen. Thank you for listening to this podcast from The Aubrey Masango Show. Listen live on weekdays between 20:00 and 24:00 (SA Time) to The Aubrey Masango Show broadcast on 702 https://buff.ly/gk3y0Kj and on CapeTalk between 20:00 and 21:00 (SA Time) https://buff.ly/NnFM3Nk Find out more about the show here https://buff.ly/lzyKCv0 and get all the catch-up podcasts https://buff.ly/rT6znsn Subscribe to the 702 and CapeTalk Daily and Weekly Newsletters https://buff.ly/v5mfet Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

The Rich Zeoli Show- Hour 2: 4:00pm- Brent Sadler—Senior Research Fellow for Naval Warfare and Advanced Technology in the Allison Center for National Security at The Heritage Foundation—joins The Rich Zeoli Show to break down Secretary of War Pete Hegseth's new combat directives to senior military officials. During a speech from Quantico, Virginia earlier today, Hegseth memorably declared: “Simply put, if you do not meet the male level physical standards for a combat position, cannot pass a PT test, or don't want to shave and look professional—it's time for a new position.” 4:30pm- From the Oval Office, President Donald Trump signed executive orders lowering the cost of pharmaceuticals and vowing to use technological innovations, like artificial intelligence, as well as increased federal funding to defeat childhood cancer. 4:40pm- While speaking with the press, President Donald Trump said the U.S. is likely to experience a government shutdown at midnight on Tuesday—noting that Democrats won't agree on a continuing resolution (CR) and are demanding government-provided healthcare for migrants residing in the country illegally. President Trump said if Democrats remain unreasonable, he will use the shutdown to make permanent cuts to the federal workforce.

Kristin Connor was living a typical life as a business litigation attorney, a job she held for about a decade and absolutely loved. Then, while she was pregnant with her second child, everything changed. Her unborn son was diagnosed with an unusual form of neuroblastoma, a cancer that's rare in children to begin with, and almost unheard of in unborn babies. After he was born, Kristin and her family spent two years going through test after test, tracking the tumor and evaluating options – all before any invasive surgery ever occurred. After trekking 3,000 miles, clear across the country, to meet with a doctor who seemed to offer the least worst alternative, the hand of god stepped in a performed what can only be described as an honest-to-goodness miracle. More on that in the interview. This experience led Kristin to leave her law career behind and dedicate her life to helping other families whose children are battling cancer. Today, Kristin is the CEO of CURE Childhood Cancer, a national nonprofit organization that raises millions of dollars each year to fund childhood cancer research and help families. September is Childhood Cancer Awareness Month, and your donations are encouraged today and every day. You can donate directly at THIS LINK. In this inspiring episode, Kristin shares more about what she loved as an attorney; the way she got involved in childhood cancer research; how she became totally disillusioned with the other cancer nonprofit organizations out there; what Major League Baseball Hall of Fame pitcher Tom Glavine and then-Commissioner Bud Selig had to do with it; why she does what she does today; and of course, the miracle she experienced. Again, please donate to Kristin's organization, CURE Childhood Cancer, at THIS LINK. No amount is too small, and every penny brings them one penny closer to saving a life. ******* If you enjoy Second Act Stories, please leave us a review here. We may read your review on a future episode! Subscribe to the Second Act stories Substack. Check out the Second Act Stories YouTube channel. Follow Second Act Stories on social media: Facebook LinkedIn Instagram Second Act Stories theme music: "Between 1 and 3 am" by Echoes.

Super Bowl-winning coach Tom Coughlin turns his focus to food insecurity in families dealing with childhood cancers.

When you sit down with Jenny Olson, you don't just hear a story—you feel it. A mother who's walked through the unthinkable, she's turned heartbreak into hope through her words, her book, and her voice on countless stages. Today, we speak not just about pediatric cancer, but about courage, love, and the fierce strength that comes only from being a mom.Featured in 'The Edge Edition' of AwareNow Magazine: www.awarenowmagazine.comGuest: Jenny OlsonHost: Allié McGuireMusic by: Laurel VioletProduced by: AwareNow Media

Send us a textIn part two of this special series, we take our listeners on the journey of childhood cancer, from diagnosis to survivorship. This is the story of Emmie Rangel, a four-year-old who was diagnosed with cancer. Because she  and her family live in a rural area, they had to travel for hours in order to receive a diagnosis and then for treatment and other emergencies. This episode shifts to a narrative format from our usual interview/question and answer format.Part 1: Hope in Every Step

In this inspiring episode of Hema Now, Catherine Glass speaks with Rob Pieters, Professor of Pediatric Oncology at Utrecht University; and co-founder of the Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands, the largest dedicated childhood cancer centre in Europe. Pieters shares his personal journey in paediatric oncology, the breakthroughs that have reshaped care, and the vision behind uniting all of the Netherlands' childhood cancer expertise under one roof.  Timestamps   00:00 – Introduction  01:06 – Pieters' start in paediatric oncology  01:29 – Biggest breakthroughs in childhood cancers  02:35 – Parts of Pieters work that bring him the most joy  03:12 - Lessons learnt from patients or their families   04:31 – The vision behind the Princess Máxima Center  08:35 – The impact of the Princess Máxima Center   10:53 – How is research funding divided?  12:55 – Evolution of treatments in paediatric oncology  15:10 – What will it take to achieve 100% cure rate in acute lymphoblastic leukaemia?  18:55 – President Elect of the European Society for Paediatric Oncology (SIOPE)  22:20 – One message of hope to families facing childhood cancer  25:10 – Pieter's three wishes for healthcare 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us a textSeptember is Childhood Cancer Awareness Month. Cancer is one of the leading causes of disease-related deaths in children. Thanks to advances in treatment, early detection and specialized pediatric oncology, survival rates for many childhood cancers have improved. This is part one of a two-episode series on childhood cancer. Mohamad Al-Rahawan, M.D., pediatric oncologist with Texas Tech Physicians, answers our questions about childhood cancer and explains why and how it's different from cancer in adults. Dr. Al-Rahawan also encourages our listeners to support the upcoming Lubbock Pediatric Cancer Walk on Saturday, Sept. 20, 2025.In the next episode, you'll hear again from Dr. Al-Rahawan and how a family dealt not only with a cancer diagnosis for their daughter, but how they managed having to travel for treatments and emergencies and being away from the rest of their family.

While there has been enormous innovation in the treatment of cancer over the past two decades, much of this has been focused on adult cancers. Despite the advent of targeted therapies and immunotherapies, the treatment of childhood cancers relies largely on chemotherapy and radiation, both of which can create lifelong side effects in developing bodies. And cancer remains the leading cause of death by disease in children in the United States and the United Kingdom. C-Further, an international consortium created by LifeArc and Cancer Research Horizons, is working to advance innovative treatments for childhood cancers. It not only provides funding to discover and develop transformative therapies to treat childhood cancers but also leverages its network to help advance promising therapies. We spoke to David Jenkinson, head of childhood cancer translational challenge at LifeArc, about the approach C-Further is taking, the scientific and economic challenges of developing treatments for childhood cancers, and why new models for advancing these therapies are needed.

The episode explores what SLPs need to know about childhood cancer. Its goal is to function as a broad introduction to this topic, primarily for SLPs who work in educational settings. The episode begins with some childhood cancer basics, including the most common types of pediatric cancers, as well as an overview of childhood cancer symptoms. The episode then examines the different ways in which childhood cancer can impact different facets of communication, including articulation, cognition, language, voice, hearing, and swallowing. The episode emphasizes the importance of collaboration when working with this population, and closes with a reminder that SLPs from educational settings have valuable support to offer children and families who have been impacted by cancer.

On this week's episode, we're joined by Louise Fox, a mother who has turned unimaginable personal loss into a powerful force for change. Louise's son George was a bright, animal-loving 12-year-old when he began having headaches that were repeatedly dismissed as harmless. Eleven months later, he died from an aggressive brain tumour. In the years since, Louise has raised hundreds of thousands of pounds for Brain Tumour Research, supported the Tessa Jowell Foundation and co-founded the Angel Mums collective to improve paediatric palliative care. She's now a leading voice in Brain Cancer Justice, a campaign demanding serious government investment and better care for brain cancer patients. Brain Cancer Justice We'll talk to Louise about how she and her family navigated those first terrifying weeks of misdiagnosis, what she learned about the shortcomings of current treatments and why she's fighting to make genome sequencing and clinical trials available to every child with a brain tumour. We'll hear about George's character and the community of “Gorgeous George” supporters who've kept his memory alive, and ask Louise what policy changes she believes could help transform brain cancer from terminal to treatable. Sign the petition for Brain Cancer Justice. Email us at info@mybaba.com Follow us on Instagram @mybabainsta and @mybabagram Show notes Sign the petition for Brain Cancer Justice. Instagram Links Brain Cancer Justice Louise Fox Angel Mums Tessa Jowel Foundation What is My Baba? My Baba provides the daily scoop on family, food and lifestyle - we're not just experts at all things parenting. Visit mybaba.com  The Content on this podcast is provided by My Baba and represents our sole opinions and views. For more information on our terms and conditions please refer to the website: https://www.mybaba.com/terms-conditions/

In this heartfelt episode of Kankakee Podcast, Drew sits down with Brady and Joy, a couple who moved their family of nine to Kankakee just two years ago. What began as a season of new beginnings quickly turned into a life-altering journey when their youngest daughter, Eloise, was diagnosed with leukemia at just three years old.Brady and Joy open up about the shock of the diagnosis, the chaos of moving while balancing hospital visits, and the strength they found in their faith, community, and each other. From Eloise's battle through treatment to the powerful moment she rang the bell and became cancer-free, this is a story of resilience, hope, and the power of community love.Send us a text Support the show

Send us a textDr. Emmanuela Amoako discusses her journey as a pediatric oncologist and her innovative COMPASS project, which aims to improve childhood cancer detection in Ghana. She emphasizes the importance of empowering caregivers and the challenges faced by children with cancer in low-income countries. The conversation also covers the need for expanded pediatric oncology units, the African Cancer Atlas initiative, and the role of bioethics in healthcare. Dr. Amoako calls for community support and crowdfunding to build a sustainable pediatric oncology center, highlighting the importance of local funding for cancer research in Africa.Support Dr. Amoako's Pediatric Cancer Project in Ghana: https://www.gofundme.com/f/help-ghanaian-children-fight-cancer-close-to-homeTo support us, consider becoming a paid subscriber on Patreon or making a one-time donation via PayPal. Subscribe to our weekly newsletter: globalhealthunfiltered.comFollow us on X (@unfiltered_gh), LinkedIn, Instagram, and TikTok.

August 29, 2025: Michael Robinson, VP of Healthcare Solutions (Americas) from Omnissa, discusses what it takes to maintain momentum during massive transitions and Omnissa's vision for autonomous workspaces. As healthcare organizations face shrinking margins and accelerating digital demands, Michael explores how strategic partnerships with Epic and CrowdStrike are reshaping the technology landscape. With the upcoming Omnissa One summit featuring a dedicated healthcare track, the conversation touches on emerging trends beyond AI—from IoT in medical devices to virtual hospitals—while examining how technology companies can genuinely align with healthcare's evolving priorities in an increasingly complex market. Register now to join Omnissa at Omnissa ONE: Learn more at Omnissa.com. Key Points: 00:54 Omnissa's Journey and Vision 05:17 Omnissa One Summit Details 08:36 Future Trends and Personal Insight X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Childhood cancer is the number one disease killer of children in the U.S. Even so, only four percent of that National Cancer Institute's budget focuses on childhood cancers. These are more than abstract statistics for this episode's guests Angela Dina and Michelle Payne. Angela and Michelle are founders of Turn it Gold, a non-profit that elevates awareness about childhood cancer and survivorship. Angela and Michelle join co-host Dr. Lynn Harter to reflect on the origin of the organization, the role of faith in their healing journeys, and the importance of athletic activism in shifting the landscape of childhood cancer care. You can read an article about Turn it Gold in the journal Health Communication at: https://www.tandfonline.com/doi/full/10.1080/10410236.2019.1651624 You can watch a trailer for the PBS documentary Realistically Ever After: A Turn it Gold Movement at: https://www.youtube.com/watch?v=KXgsV5Tjn5o

August 28, 2025: In this Keynote Rewind episode, we explore how organizations balance the revolutionary potential of generative AI with the critical need for rock-solid infrastructure. Leaders share stories of mobile clinics outperforming traditional facilities, drone deliveries reaching remote islands, and home-based care achieving superior outcomes to hospital stays. With TEFCA enabling secure data exchange across state lines and remote patient monitoring saving children's lives, what happens when healthcare finally has the framework to scale innovation?  Key Points: Taylor Davis - [00:01:00] Glen Tullman - [00:02:00] Doug King - [00:03:00] B.J. Moore - [00:04:00] Shakeeb Akhter - [00:05:00] Chad Brisendine - [00:06:00] Bradd Busick / Brent Lamm - [00:07:00] Tim Skeen / Andrew Rosenberg - [00:08:00] Mickey Tripathi - [00:09:00] Aneesh Chopra / Craig Richardville - [00:11:00] Christopher Longhurst - [00:12:00] and [00:14:00] Daniel Barchi - [00:12:00] Alistair Erskine - [00:12:00] and [00:14:00] Keith Perry - [00:13:00] Stephen Klasko - [00:14:00] X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

August 27, 2025: Dan Dodson, CEO of Fortified Health Security, discusses how healthcare organizations are rethinking cybersecurity strategy amid mounting financial pressures. Dan shares insights from their Nashville Executive Briefing Center, where healthcare leaders are uncovering critical gaps in their security programs. As AI tools spread faster than anyone anticipated—with physicians using platforms that security experts haven't even heard of—how do organizations balance innovation with control? With Medicare cuts looming and every cybersecurity dollar representing money moved away from patient care, are healthcare systems getting real value from their fragmented tool investments?  Key Points: 01:31 Executive Briefing Center Experience 06:27 Cyber Survivor Podcast 11:02 Midyear Horizon Report Insights 13:47 Lightning Round Questions X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

August 26, 2025: Anika Gardenhire, RN, Chief Digital and Transformation Officer at Ardent Health, joins Reid Stephan, VP and CIO at St. Luke's Health System, to discuss the complicated world of nursing. As healthcare faces workforce shortages and an aging population, the discussion examines whether current documentation requirements are actual regulations or simply historical inertia that's never been questioned. Can we redesign nursing documentation to capture both the measurable "science" and the intuitive "art" that experienced nurses bring to patient care? Anika envisions a future where technology amplifies rather than replaces the human elements that define exceptional nursing care. Key Points: 01:03 Challenges with Nursing Flow Sheets 09:39 Reimagining Nursing Documentation 17:46 Role of EHRs in Future Nursing 21:25 AI and Technology in Healthcare 24:57 Final Thoughts and Encouragement X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

August 25, 2025: Chase Franzen, VP and CISO at Sharp Healthcare, discusses how they transformed their cybersecurity training into something so engaging that employees actually call it fun. But as AI capabilities advance at breakneck speed, what happens when traditional phishing indicators disappear and deepfakes become indistinguishable from reality? Chase discusses Sharp's AI ethics committee and their approach to balancing innovation with responsibility, while sharing candid thoughts about AI's true costs. The conversation also explores how failure and discomfort drive growth, touching on everything from real estate disasters to the joy of flying planes Key Points: 02:51 Diverse Career Paths: Real Estate, Teaching, and More 08:36 Innovative Cyber Ambassador Program 13:03 AI Cybersecurity Concerns 21:57 Lightning Round: Quotes, Failures, and Airplanes X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

August 25, 2025: Margaret Ptacek, Vice President of Client Solutions from Experis Health, tackles three critical shifts happening in healthcare today. The conversation explores Hackensack Meridian's statewide hospital-at-home expansion and examines how healthcare systems can deliver acute-level care in patients' homes without compromising safety or quality. When staffing shortages threaten a new hospital's ability to provide basic services, the discussion turns to virtual solutions and workforce resilience strategies. Can technology and strategic partnerships solve healthcare's most pressing operational challenges while maintaining financial sustainability? Margaret shares insights from real-world implementations that are reshaping how care is delivered beyond traditional hospital walls. Key Points: 01:38 Remote Patient Monitoring and AI in Healthcare 07:01 Hospital at Home: Expanding Care Models 13:54 Addressing Staffing Shortages in Healthcare 18:22 Blending Technology and Human Touch in Healthcare News Articles:  Remote Patient Monitoring (RPM) Devices Transform Patient Monitoring, Show Promise for Reshaping Cancer Care Hackensack Meridian Expands Hospital-at-Home to Improve Patient Care Statewide New Hospital Struggles with Staffing Shortages X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

This week's guest is Ashley Cain, a former professional footballer turned TV personality, endurance athlete and advocate for children with cancer. The death of his daughter Azaylia from leukemia in 2021 inspired The Azaylia Foundation, through which he's completed extreme endurance feats to raise awareness and funds for childhood cancer. More recently he has appeared and co-produced the BBC's Into The Danger Zone which has received incredible feedback. He has welcomed two sons, Aliyas and Atlas, while continuing charity work and public engagement to further enhance the legacy of his late daughter, Azaylia In this episode, we follow Ashley Cain's deeply personal journey from his daughter Azaylia's leukemia diagnosis, remission and tragic relapse, to the profound impact she had on his life. Ashley reflects on being blessed to be her father, her incredible strength and his hope that she is looking down on him, proud of his efforts. He shares how raising awareness of childhood cancer, now the leading child killer in the UK has become his mission, leading to the creation of The Azaylia Foundation and extreme physical challenges in her honour. We explore how battling through these feats keeps him close to her, his experience of becoming a father again and navigating the mix of guilt, joy and love.   02:53 – Background on Ashley Cain and Azaylia's leukemia journey 21:45 – The power of having a purpose 23:45 – Life after Azaylia's passing 26:38 – Childhood cancer: the no.1 killer of children in the UK 29:42 – Ashley's challenges in tribute to Azaylia 47:25 – Becoming a father again twice in 1 year 01:11:58 – Dealing with public criticism whilst focusing on his purpose   Show Sponsors:   AYS Developers: A design-focused company dedicated to crafting exceptional homes, vibrant communities, and inspiring lifestyle experiences. https://bit.ly/AYS-Developers     Allsopp & Allsopp: Redefining real estate, through cutting-edge technology and setting new standards for seamless, elevated customer experience. Keep moving with Allsopp & Allsopp. https://bit.ly/Allsopp-and-Allsopp    Socials:   Follow Spencer Lodge on Social Media https://www.instagram.com/spencer.lodge/?hl=en  https://www.tiktok.com/@spencer.lodge  https://www.linkedin.com/in/spencerlodge/  https://www.youtube.com/c/SpencerLodgeTV  https://www.facebook.com/spencerlodgeofficial/    Follow Ashley Cain on Social Media https://www.tiktok.com/@mrashleycain https://www.instagram.com/mrashleycain/  

This week's cybersecurity updates cover three critical stories: Workday discloses a data breach connected to ongoing Salesforce compromises by the Shiny Hunters group, CEO impersonation scams using deepfake technology surge past $200 million in Q1 losses, and transcription service Otter AI faces a class action lawsuit over alleged mishandling of sensitive meeting data. Drex emphasizes the importance of security awareness training, multi-factor authentication, and establishing "trust but verify" cultures that protect employees who take extra verification steps.Remember, Stay a Little Paranoid X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

August 21, 2025: In this Keynote Rewind, healthcare leaders are hitting their breaking point, and the numbers tell only part of the story. This episode goes beyond burnout statistics to reveal how some organizations are quietly transforming healthcare work—reducing alert fatigue from a million notifications to under 100,000, implementing "wellness sprints" where IT teams shadow physicians, and achieving belonging scores that surpass industry benchmarks. Can these targeted interventions really address the deeper issues of culture and connection that drive people away from healthcare? Through conversations with leaders who've been to the edge and back, we explore what's actually working to rebuild trust, restore balance, and create systems worth staying in. Key Speakers: Joel Klein - [00:01:00] Erica Olenski - [00:03:00] Ian Koniak - [00:04:00] Erica Olenski - [00:05:00] Deborah Proctor - [00:06:00] Jake Lancaster, MD - [00:07:00] Theresa McDonnell - [00:08:00] Bridget Barnes - [00:09:00] Scott MacLean - [00:10:00] Marijo Rugh - [00:11:00] Tanya Townsend / Theo Theodosiou - [00:13:00] Michael Restuccia - [00:14:00] Alastair Erskine, MD - [00:16:00] Chris Harper - [00:19:00] Chero Goswami - [00:19:00] Aaron Miri - [00:20:00] X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

August 20, 2025: Michael Fredrickson, VP of Sales for US Healthcare from Rubrik, discusses cyber resilience when patient care is on the line. Michael reveals the sobering reality that many younger nurses have never worked without electronic health records. What happens when these systems fail, and staff trained entirely on digital platforms must suddenly revert to pen and paper? As they discuss new innovations in identity resilience and AI agent controls, they raise important questions: Can healthcare organizations realistically meet the proposed 72-hour recovery requirements?  Join the Rubrik Healthcare Summit on September 10 and learn how to prepare for, respond to, and recover from cyberattacks. Register at events.rubrik.com/healthcare. Key Points: 02:20 Rubrik's Mission and Cybersecurity Focus 09:36 Future of Rubrik and AI Integration 16:10 Building a Customer-Centric Culture X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

August 19, 2025: Dr. William Morgan, MD, CEO at Copiah County Medical Center, discusses his unexpected four-year transformation of CCMC, a rural Mississippi hospital that's now pioneering AI-driven healthcare solutions. William discusses how partnerships with companies like Neteera have enabled everything from AI fall prevention to real-time patient monitoring, fundamentally changing how rural communities access specialist care. How do you balance cutting-edge technology with the human connection that patients need most? The conversation explores practical strategies for rural healthcare leaders facing resource constraints and potential funding cuts. Key Points: 03:13 Technological Advancements in Rural Healthcare 05:31 Real-Life Impact Stories 07:37 Expanding Capabilities and Future Vision 11:15 Advice for Rural Health Leaders 13:56 Cultural Transformation and Conclusion X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

August 18, 2025: Stephanie Lahr, MD, Founder of Vital Thread Advisory, reveals her transition from healthcare executive to solo consultant. What drives a seasoned physician-executive to question decades of traditional employment and embrace the uncertainty of independent consulting? Stephanie discusses overcoming the fear of leaving structured organizations, the practical realities of building Vital Thread Advisory, and why she believes healthcare companies need specialized expertise without full-time commitments. How do you navigate imposter syndrome while positioning yourself as the connector—the "thread"—that brings together clinical insight, operational know-how, and emerging technology? Her journey challenges assumptions about career security and explores whether the current healthcare market is creating new opportunities for those willing to redefine professional success. Key Points: 03:47 The Birth of Vital Thread Advisory 09:18 Navigating the Solo Journey 17:15 Advice for Aspiring Solo Practitioners 32:27 Speed Round  X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

I have often said that different people grieve differently. Today's guest, Lori, adds a new twist to that statement. She lost two of her four sons almost 30 years apart from each other, and she is grieving so much differently now than she did the first time around, showing that the same person can grieve similar losses differently as well. The stories of Michael and Logan's deaths are far different. Michael died at age 2 of an aggressive type of cancer called neuroblastoma. He died after 9 months of treatment in his mother's arms at the hospital, which she says gave her time to say goodbye, but also forced her to watch him endure pain and suffering. Twenty-five-year-old Logan, on the other hand, died suddenly from an accidental drug overdose in his apartment. Logan was there one day and gone the next. Lori says that after losing Michael, she became an extremely compassionate person. She and her husband turned to each other for support. Loris describes him as her rock. She was very involved in church, turning to her faith to help ease the intense pain of loss. Over the years, Lori says that her biggest fear was that she might lose another one of her three remaining boys, but despite Logan's long history of mental health struggles, she did not ever think this would happen to them again. Then, 18 months ago, the unimaginable occurred - Logan died, too. After Michael died, compassion emerged. This time, however, fear and anger are the dominant emotions. She has trouble going out in public. Lori hasn't gone to church, and her faith feels broken. Her relationship with her husband has been damaged, and she has moved in with her two living sons, who are now her two rocks. Online support groups and podcasts have become her coping strategies.  These vastly different responses may seem surprising. I know they were unexpected to Lori, but there is a lesson here.  Grace. We need to give others and ourselves grace. We cannot control our feelings or our responses to grief. We need to feel our emotions, whatever they may be, and work through them. Through hard work, hope for the future may come again, for Lori and for us.

On this week's episode of The 1 Girl Revolution Podcast, we welcome Leia Hunt — cancer survivor, inspirational speaker, author, and founder of Leia's Kids - a nonprofit dedicated to supporting children and families battling cancer. Leia's own cancer journey began when she was just two years old, after being diagnosed with a rare form of eye cancer. She endured 26 surgeries and multiple rounds of chemotherapy, ultimately losing sight in one eye. But instead of letting her struggles define her, Leia turned her pain into purpose — speaking at the White House, working alongside the American Cancer Society and the Eye Tumor Research Foundation, and inspiring countless others through her story. At just 18 years old, while still in high school, Leia founded Leia's Kids — a nonprofit dedicated to supporting children and families battling childhood cancer. As a survivor herself, Leia knows firsthand the challenges these children and their families face. Her organization provides financial grants, hosts dream parties, organizes mental health retreats, and so much more — offering not just support, but joy, hope, and a sense of community during some of life's hardest moments. In this episode, you'll hear: ✨ Leia's incredible journey as a child with cancer and now as a cancer survivor; ✨ How her childhood experiences inspired her to start Leia's Kids at just 18; ✨ The heart and mission behind Leia's Kids — and the life-changing impact they have on families; ✨ Stories from the dream parties, retreats, and programs she's created; ✨ How faith and resilience have guided her through challenges; ✨ What she's learned about life, hope, and community from the children she serves; ✨ And so much more!

August 14, 2025: Healthcare has moved from "what if" to "what now" with AI, as health systems quietly implement artificial intelligence across operations from revenue cycle to bedside care. Bill Russell explores how virtual care adoption jumped from 3% to 95% in three months, questioning whether healthcare's barriers are truly technological or cultural. As hospitals face mounting complexity and clinicians struggle with what leaders call a "wealth of data and poverty of insights," AI is addressing everything from scheduling optimization to diagnostic support—often without patients realizing it. The episode examines current implementations like virtual nurses handling administrative tasks and AI-assisted radiology reads, while exploring the provocative prediction that practicing without AI assistance may soon be considered below standard care.  Key Points: [00:02:00] - Pete Clardy [00:03:00] - Michael Pfeffer [00:04:00] - Kristin Myers [00:05:00] - BJ Moore [00:06:00] - Shez Partovi [00:07:00] - Marty Paslick [00:08:00] - Jennifer Owens [00:09:00] - CT Lin [00:09:00] - Dirk Stanley [00:10:00] - Cris Ross [00:11:00] - Zafar Chaudry [00:12:00] - Shakeeb Akhter [00:12:00] - Brad Reimer [00:13:00] - Albert Oriol [00:14:00] - Seth Hain [00:15:00] - Christopher Longhurst, MD, MS [00:16:00] - Taylor Davis X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

August 13, 2025: Eric Utzinger, Co-Founder and Chief Client Officer at Revuud, tackles the world of healthcare consulting. Drawing from 15 years in healthcare consulting, Eric reveals how the industry shifted around 2013, creating a system where traditional staffing firms often add little value beyond letterhead while charging substantial markups. What happens when technology enables direct access to pre-vetted talent pools? The conversation explores how marketplace platforms can eliminate intermediary costs while maintaining quality control, and why the assumption that higher costs equal better consultants may be costing health systems more than they realize. Eric addresses the critical balance between project success, talent vetting, and transparent pricing in an industry where finding the right IT expertise quickly can make or break major implementations. Key Points: 02:08 Challenges in Healthcare Consulting 04:53 Client and Talent Interaction 06:52 Vetting and Quality Assurance 09:56 Common Mistakes in Hiring Contractors X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

August 12, 2025: Dr. Zafar Chaudry, SVP, CDIO, and AI Officer, speaks with Dr. Vittorio Gallo, Chief Scientific Officer at Seattle Children's Research Institute, about the transformation happening in pediatric research. As healthcare shifts from traditional lab work to data-driven science, how are research institutions keeping pace with the explosion of information they're generating? Vittorio discusses breakthrough therapies currently in development, including the first clinical trial for cell immunotherapy in pediatric lupus and innovative approaches to treating neonatal brain injuries. But with massive datasets requiring decades of storage and AI models now identifying developmental disorders through behavioral analysis, what does this mean for the relationship between technology teams and researchers?Key Points:03:40 Innovative Pediatric Therapies10:53 Future Directions in Data Science16:02 Future Projects and AI Applications22:44 Mentorship and Advice for Young ScientistsX: This Week HealthLinkedIn: This Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Debi Mitchell's son Austin was diagnosed with Stage 3 Acute T Cell Lymphoblastic Non Hodgkins Lymphoma in 2021 when he was 12 years old, under the assumption that his issue before this diagnosis had to do with Asthma. Today, Austin is doing very well and is trying to establish himself as an actor. While spending her time during Austin's treatment at a Northern California Hospital which would become affectionately known as the "Kaiser Resort", Debi met other mom's who were with their children and were being treated for different forms of Pediatric Cancer. During this time in the "Kaiser Resort" these moms coalesced to form the MAMA BEARS FIGHTING CHILDHOOD CANCER Non-Profit, a Non-Profit which now has established Roots in a number of Northern California Hospitals. 

August 7, 2025: In this Keynote recap, Bill takes viewers through the untold reality behind digital transformation: the biggest obstacles aren't technological, they're human. What happens when you're tasked with building an entire IT department from scratch, or when you have to justify why a hospital even needs a CIO? As organizations develop their fourth digital roadmap and AI promises to revolutionize care delivery, seasoned executives reveal how clinical experience shapes risk tolerance, why traditional hiring practices miss diverse talent, and the critical mistake of treating innovation as a separate function. From Penn Medicine's team-building challenges to Utah's rural care initiatives, these leaders offer candid insights about balancing budgets with human resources, communicating effectively up and down the chain, and preparing organizations for an AI-enabled future without creating costly silos.Key Points:[00:01:00] - Michael Restuccia [00:02:00] - Deborah Proctor - Donna Roach [00:03:00] - Susan Ibanez [00:04:00] - Lee Milligan [00:06:00] - Chuck Podesta [00:07:00] - Joel Klein [00:08:00] - David Butler, MD [00:09:00] - Tressa SpringmannX: This Week HealthLinkedIn: This Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

August 6, 2025: Lisbeth Votruba, Chief Clinical Officer at AvaSure and a third-generation nurse, discusses how virtual care technology is transforming healthcare delivery. How can AI-powered platforms help nurses return to more personalized, joyful patient care while addressing the growing crisis of workplace violence in hospitals? Lisbeth shares her journey from ICU nurse to tech executive, discussing innovative solutions such as ambient monitoring and wake word technology that protect both patients and staff. What role should nurses play in shaping healthcare's digital future, and how can the profession leverage its trusted status to drive meaningful change? The conversation also touches on the emotional toll of caregiving and Lisbeth's advocacy work supporting healthcare workers in recovery. Key Points: 03:45 Innovations in Nursing Technology 08:12 Challenges in Nursing Violence 11:49 Emotional Well-being of Nurses X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

This episode covers three critical cybersecurity developments affecting healthcare organizations. First, FBI warnings about Scattered Spider ransomware group targeting employees through Slack and Microsoft Teams, including their alarming tactic of creating fake identities to join incident response calls and monitor remediation efforts. Second, leaked chat logs from the Conti ransomware group reveal these criminal organizations operate like structured tech startups with HR policies, management layers, and performance reviews - highlighting the sophisticated nature of modern cyber threats. Finally, CrowdStrike intelligence reveals over 900 North Korean operatives have quietly embedded themselves in US companies using deepfakes and fake identities, wiring paychecks back to the regime. The episode also mentions CISA's new free Thorium tool for malware analysis and forensic investigations.X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

July 31, 2025: Bill Russell, Drex DeFord, and Sarah Richardson preview their upcoming show changes while tackling critical CIO challenges. They discuss "CIO escape rooms"—high-pressure scenarios such as your EHR vendor going out of business or handling a 3 AM security breach. How do healthcare IT leaders navigate the treacherous waters of CEO transitions, and what's the real difference between a wartime and peacetime CIO? The conversation turns to compensation strategy for a hospital system, examining whether geography or specific leadership "phenotype" should drive salary decisions. They explore what CIOs would prioritize with unlimited budgets, from infrastructure overhauls to real-time data platforms, while questioning who truly deserves the CIDO title in an industry where keeping the lights on battles against driving transformation. Key Points:03:45 CIO Challenges and Escape Room Scenarios06:52 New Podcast Channels and Formats14:03 Real-Time Data Governance and ROI15:51 Automation and Patching in Health Systems17:47 Hiring and Compensation for Health System CIOs20:56 The Role and Value of a good CIDOsX: This Week HealthLinkedIn: This Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

July 30, 2025: Marco Casale, Systems Integration Architect at the University of Rochester, and Drew Ivan, Chief Architect at Rhapsody, join Bill to discuss healthcare interoperability. What would happen if these critical integration platforms suddenly went down, and why does even Epic need hundreds of external connections to keep hospitals running? The discussion covers the evolution from HL7 V2 to FHIR standards, how the pandemic necessitated the massive scaling of data exchanges, and the ongoing challenge of integrating disparate healthcare systems to communicate. Key Points: 03:10 Interoperability and Integration Solutions 10:27 Automation in Healthcare 11:07 Integration During the Pandemic 18:57 Future of Healthcare Integration X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Drex covers three critical cybersecurity threats impacting healthcare and beyond: North Korean operatives using deepfakes and stolen identities to infiltrate US companies as remote workers, the Allianz life insurance breach affecting 1.4 million customers through social engineering attacks, and the TTEA dating app's massive data exposure that compromised women's safety information. Essential insights on vetting remote employees, defending against social engineering, and app security risks.Remember, Stay a Little Paranoid X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Even cyber pros have technical issues sometimes – our camera caught a bug, but the audio is clean and packed with security insights! July 28, 2025: Aaron Heath, CISO and Cybersecurity Counsel at the Medical University of South Carolina, and Brian Zegers, Information Security Officer at Lee Health, discuss a variety of security topics. The conversation takes a turn when both leaders address their growing concerns about AI's rapid evolution from helpful tools to autonomous agents with privileged network access. How do you prepare for ransomware recovery when your backup strategies have blind spots? And what happens when AI agents start operating independently within healthcare networks? As these security leaders balance innovation with protection, they ask: Are we moving too fast with AI automation, and how do we secure technologies that are changing faster than our security frameworks can keep pace? Key Points: 03:08 Brian's Ransomware Recovery Initiative 08:41 The Role of AI in Cybersecurity 13:47 Talent Recruitment Strategies 17:48 Career Journeys in Cybersecurity 21:32 Fun and Personal Insights X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

July 24, 2025: Theresa McDonnell, Chief Nursing Executive and SVP at Duke University Health System, discusses how she maintains her clinical practice while leading strategic transformation across a billion-dollar organization. What specific changes helped Duke reduce nurse turnover from 21% to 11%? Theresa discusses her role in orchestrating the complex $1.7 billion merger that created the Fred Hutchinson Cancer Center and shares how Duke's innovation hackathons have engaged over 10,000 frontline staff. As healthcare faces mounting workforce shortages and an aging population, what role should AI play in enhancing rather than replacing human care? The conversation explores practical approaches to empowering healthcare workers and how the future of care is centered on preventing sickness rather than just treating illness. Key Points: 05:03 Nurse-Led Innovation at Duke 11:03 Strategic Transformation and Mergers 19:04 Balancing Patient Care and Innovation 24:22 Advice for Early Career Clinicians 27:08 Speed Round and Closing Remarks X: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Matt Dun left school at 17 to join the Australian navy as a submariner and later finished his high school certificate as an adult attending TAFE at night.He then trained in biomedical science and was researching childhood leukaemia when his family received some devastating news, their little daughter Josie was diagnosed with terminal brain cancer.Matt turned all his energy and expertise into searching for treatments to help Josie and other children like her.He found running was one thing that helped him cope with the stress and pain of his daughter's illness, and with his wife founded the charity, RUN DIPGFurther informationThe charity founded by Matt and Phoebe Dun is RUN DIPGFind out more about the Conversations Live National Tour on the ABC website.This episode of Conversations was produced by Jen Leake, executive producer is Nicola Harrison.It explores childhood brain cancer, biomedical science, grief, family, DIPG, drug trials, research, submarines, the Australian Navy, running.